This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Cancer-Associated Thrombosis
  • /
  • A Randomized Phase II Open Label Study to Compare ...
Clinical trial

A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism (PRIORITY)

Read time: 2 mins
Last updated:5th Jan 2020
Status: Recruiting
Identifier: NCT03139487
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest